Overview


According to FutureWise analysis the market for Ibuprofen API in 2023 is US$ 7.5 billion, and is expected to reach US$ 9.5 billion by 2031 at a CAGR of 3.5%.

Ibuprofen is a white crystalline powder. The chemical name for ibuprofen is 2-(4-isobutylphenyl) propionic acid, and its molecular formula is C13H18O2. Ibuprofen API (Active Pharmaceutical Ingredient) is the chemically active ingredient in ibuprofen that is used to create various forms of the medication, such as tablets, capsules, and syrups. It is a non-steroidal anti-inflammatory drug that is used to relieve pain, reduce fever, and decrease inflammation. It works by inhibiting the production of certain chemicals in the body that cause inflammation and pain.

Ibuprofen works by inhibiting the production of prostaglandins, which are chemical messengers that cause pain, fever, and inflammation in the body. By reducing the production of these chemicals, ibuprofen can help to alleviate pain and reduce inflammation. Ibuprofen is available in both prescription and over-the-counter forms. It is used to cure a variety of conditions, including headache, menstrual cramps, toothache, arthritis, and fever. However, it should be used with caution, as it can have side effects such as stomach upset, gastrointestinal bleeding, and kidney damage. Ibuprofen is typically administered orally, either as tablets, capsules, or liquid suspensions. It is rapidly absorbed in the gastrointestinal tract and reaches peak plasma concentrations within 1-2 hours after ingestion. Ibuprofen has a half-life of approximately 2-4 hours and is metabolized by the liver.

FutureWise Market Research has published a report that provides an insightful analysis of Ibuprofen API market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that the Ibuprofen API market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • BASF SE
  • Biocause Inc
  • IOL Chemicals And Pharmaceuticals Limited
  • SI Group, Inc
  • Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd
  • Solara Active Pharma Sciences Limited.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Ibuprofen API Market:

In November 2022, the advanced, multipurpose API production facility owned by Solara Active Pharma Sciences Limited in Vishakhapatnam, Andhra Pradesh, received Certificate of Suitability (CEP) approval from the European Directorate for the Quality of Medicine (EDQM) for the manufacture of ibuprofen API.

The ibuprofen API (Active Pharmaceutical Ingredient) market refers to the market for the raw ingredient used to manufacture ibuprofen-containing drugs, such as tablets and capsules. This market is dominated by a few large manufacturers and is used by pharmaceutical companies to produce their own brand of ibuprofen products. The demand for ibuprofen API is driven by factors such as an aging population, increasing cases of arthritis, high effectiveness of ibuprofen API in maternal health care and rising cases of migraine. However, short and long-term side effects, price volatility and increased competition from generic manufacturers may impact the market growth. This market is anticipated to grow in the years to come.

By Product

  • Rx
  • OTC

By Application

  • Headache
  • Arthritis
  • Others

By End User

  • CROs and CMOs
  • Biopharmaceutical and Pharmaceutical Companies
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. The Asia-Pacific market is predicted to have exponential growth throughout the forecast period due to rising healthcare costs. Additionally, the Asia-Pacific area has drawn major pharmaceutical and biotechnology companies from throughout the world due to low manufacturing expenses in China and India, which have led to an increase in production facilities. Top market share holder companies in ibuprofen API market are BASF SE, Merck, IOL Chemicals and Pharmaceuticals Limited, HUBI Biocause Pharmaceuticals, and SI Group Inc. In India, there were approximately 137.9 million individuals over the age of 60 in 2021, according to the Elderly in India 2021 study. By the year 2031, the numbers are expected to increase to 193.8 million. The forecasted population growth is anticipated to boost the demand for novel pain management because the senior population is predisposed to many chronic ailments. Over the course of the projected period, this is expected to fuel market expansion.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the global ibuprofen API market by product, by application, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Ibuprofen API Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Ibuprofen API Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Ibuprofen API Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Ibuprofen API Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Rx
        2. OTC

  • 8.   Ibuprofen API Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Headache
        2. Arthritis
        3. Others

  • 9.   Ibuprofen API Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. CROs and CMOs
        2. Biopharmaceutical and Pharmaceutical Companies
        3. Others

  • 10.   North America Ibuprofen API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Ibuprofen API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Ibuprofen API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Ibuprofen API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Ibuprofen API Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. BASF SE
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. BIOCAUSE Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. IOL Chemicals And Pharmaceuticals Limited
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. SI Group, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co. Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Solara Active Pharma Sciences Limited
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients